Topic: National Cancer Research Network; Subtopic: Lymphoma; Disease: Lymphoma (Hodgkin's) research hub

Brentuximab vedotin In patients with Hodgkin lymphoma

This study tests a targeted drug called brentuximab vedotin for people with classical Hodgkin lymphoma. It is designed for patients who cannot have standard chemotherapy due to older age, general frailty, or other health problems affecting their heart or lungs. It aims to offer an effective, gentler alternative treatment.